These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26768967)

  • 1. Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model.
    Seo J; Lee C; Hwang HS; Kim B; Thao le Q; Lee ES; Oh KT; Lim JL; Choi HG; Youn YS
    Pulm Pharmacol Ther; 2016 Feb; 36():53-61. PubMed ID: 26768967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
    Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues.
    Thao le Q; Byeon HJ; Lee C; Lee S; Lee ES; Choi HG; Park ES; Youn YS
    Int J Pharm; 2016 Jan; 497(1-2):268-76. PubMed ID: 26657273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
    Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
    Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
    Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
    Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
    Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endostatin-derived peptide orally exerts anti-fibrotic activity in a murine pulmonary fibrosis model.
    Nishimoto T; Mlakar L; Takihara T; Feghali-Bostwick C
    Int Immunopharmacol; 2015 Oct; 28(2):1102-5. PubMed ID: 26315492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity.
    Zhao L; Zhou Y; Gao Y; Ma S; Zhang C; Li J; Wang D; Li X; Li C; Liu Y; Li X
    Int J Pharm; 2015 Apr; 483(1-2):180-7. PubMed ID: 25681723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
    Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
    Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin].
    Li W; Hu Y; Yuan W; Li L; Huang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):221-5. PubMed ID: 22381763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of tacrolimus colloidal dispersion for inhalation.
    Watts AB; Peters JI; Talbert RL; O'Donnell KP; Coalson JJ; Williams RO
    Eur J Pharm Biopharm; 2011 Feb; 77(2):207-15. PubMed ID: 21130874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulization of nanoparticulate amorphous or crystalline tacrolimus--single-dose pharmacokinetics study in mice.
    Sinswat P; Overhoff KA; McConville JT; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1057-66. PubMed ID: 18406587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary delivery of therapeutic proteins based on zwitterionic chitosan-based nanocarriers for treatment on bleomycin-induced pulmonary fibrosis.
    Zhang G; Mo S; Fang B; Zeng R; Wang J; Tu M; Zhao J
    Int J Biol Macromol; 2019 Jul; 133():58-66. PubMed ID: 30981773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
    Hagiwara SI; Ishii Y; Kitamura S
    Am J Respir Crit Care Med; 2000 Jul; 162(1):225-31. PubMed ID: 10903246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.
    Cai Y; Yoneda M; Tomita T; Kurotani R; Okamoto M; Kido T; Abe H; Mitzner W; Guha A; Kimura S
    BMC Pulm Med; 2015 Jul; 15():72. PubMed ID: 26178733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.
    Deuse T; Blankenberg F; Haddad M; Reichenspurner H; Phillips N; Robbins RC; Schrepfer S
    Am J Respir Cell Mol Biol; 2010 Oct; 43(4):403-12. PubMed ID: 19880819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice.
    Lee SH; Lee EJ; Lee SY; Kim JH; Shim JJ; Shin C; In KH; Kang KH; Uhm CS; Kim HK; Yang KS; Park S; Kim HS; Kim YM; Yoo TJ
    Exp Lung Res; 2014 Apr; 40(3):117-25. PubMed ID: 24624895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin Based Nanomedicine for Enhancing Tacrolimus Safety and Lymphatic Targeting Efficiency.
    Zhang Y; Pan J; Li H; Yu D; Wu T; Wang L; Wang Y; Zhou L; Zheng S
    J Biomed Nanotechnol; 2019 Jun; 15(6):1313-1324. PubMed ID: 31072438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.